Chicken egg ovalbumin OVA (Gal d 2, 257-264) peptide control peptide

General information
 

Name:
Chicken egg ovalbumin OVA (Gal d 2, 257-264) peptide control peptide
Size:
1 mg
Catalog no:
OVA2571-P
Price:
282 EUR
 

Additional extra details
 

  • Stock availability

    Available

    Category

    Antibody Blocking Peptide

    Antibody type

    N/A

  • Antibody host

    N/A

    Antibody conjugate

    N/A

    Technical datasheet

    Contact Gentaur to request the datasheet or ask our specialists for more information.

  • Notes

    The Chicken egg ovalbumin OVA (Gal d 2, 257-264) peptide control peptide is manufactured for Research Use Only or for diagnostics purposes.

    Tissue

    control

    Properties

    Chickens like all bird species have IgY antibodies that are very stable and found in the yolk. Gallus Gallus domestica is the Latin name of the Chicken.

  • Description

    Isotype or positive controls by peptides, antibodies and deactivated samples.Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.

    Gene

    Ovalbumin (abbreviated OVA) is the main protein found in egg white, making up 60-65% of the total protein. Ovalbumin displays sequence and three-dimensional homology to the serpin superfamily, but unlike most serpins it is not a serine protease inhibitor. The function of ovalbumin is unknown, although it is presumed to be a storage protein. OVA is also the best characterized and the first antigen proteins used as a transgene to make transgenic mice. Many different transgenic mouse models have systemic OVA expression driven by the ubiquitously expressed b-actin promoter or tissue-specific OVA expression with insulin promoter to drive the transgene expression, for studying type I diabetes, or in different isoforms, secreted or cell-membrane associated, and more recently as inducible transgene models. These C57BL/6 mice, BALB/c mice models are well characterized, and have contributed to our understanding of immunogenicity and tolerance by the OVA model.